Academic researchers, R&D teams, teachers, students, policy makers and the media all rely on us to share knowledge that is reliable, accurate and cutting-edge. Introducing a new discovery about 10034-20-5, Name is (2S,3R,4R,5S,6R)-6-(Acetoxymethyl)-3-aminotetrahydro-2H-pyran-2,4,5-triyl triacetate hydrochloride, Recommanded Product: 10034-20-5.
The present invention discloses a two-hydrogen porphine glucoside compound and its preparation method and application, which belongs to the technical field of chemical medicine. The invention the Dihydroporphine glucoside compound, by selectively with tumor cell surface high expression of glucose transport protein binding, thereby improving the light, quick targeting to tumor cells. In vitro anti-tumor activity evaluation display, the same as contradistinguished Dihydroporphine e6 compared, the invention the Dihydroporphine glucoside compounds on human liver cancer cell Hep G2 has higher photoactive and sound activeness. Can be used for tumor treatment of photodynamic therapy, Acoustodynamic in methods of treatment photosensitizer photosensitizers of the preparation. The process of the invention is simple, easy control of reaction conditions, which is beneficial to manufacture. (by machine translation)
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Recommanded Product: 10034-20-5. In my other articles, you can also check out more blogs about 10034-20-5
Reference：
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics